Guggenheim Capital’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-145,108
| Closed | -$570K | – | 2192 |
|
|
2019
Q3 | $570K | Buy |
145,108
+60,278
| +71% | +$237K | ﹤0.01% | 1562 |
|
|
2019
Q2 | $1.26M | Buy |
84,830
+14,533
| +21% | +$216K | 0.01% | 1242 |
|
|
2019
Q1 | $1.75M | Sell |
70,297
-9,323
| -12% | -$231K | 0.01% | 1133 |
|
|
2018
Q4 | $1.43M | Buy |
79,620
+3,389
| +4% | +$60.9K | 0.01% | 1209 |
|
|
2018
Q3 | $2.24M | Buy |
76,231
+11,596
| +18% | +$341K | 0.01% | 1181 |
|
|
2018
Q2 | $2.94M | Buy |
64,635
+9,780
| +18% | +$445K | 0.02% | 1023 |
|
|
2018
Q1 | $2.9M | Buy |
54,855
+2,262
| +4% | +$119K | 0.01% | 1378 |
|
|
2017
Q4 | $3.58M | Sell |
52,593
-15,249
| -22% | -$1.04M | 0.01% | 1233 |
|
|
2017
Q3 | $5.59M | Buy |
67,842
+12,840
| +23% | +$1.06M | 0.01% | 998 |
|
|
2017
Q2 | $5.15M | Buy |
55,002
+4,003
| +8% | +$375K | 0.01% | 1002 |
|
|
2017
Q1 | $3.25M | Sell |
50,999
-12,569
| -20% | -$800K | 0.01% | 1291 |
|
|
2016
Q4 | $2.82M | Buy |
+63,568
| New | +$2.82M | 0.01% | 1415 |
|
|
2016
Q2 | – | Sell |
-104,121
| Closed | -$2M | – | 2950 |
|
|
2016
Q1 | $2M | Sell |
104,121
-12,987
| -11% | -$249K | 0.01% | 1571 |
|
|
2015
Q4 | $4.1M | Buy |
117,108
+25,241
| +27% | +$883K | 0.01% | 1114 |
|
|
2015
Q3 | $8.45M | Sell |
91,867
-12,609
| -12% | -$1.16M | 0.03% | 819 |
|
|
2015
Q2 | $9.18M | Buy |
104,476
+6,585
| +7% | +$579K | 0.02% | 871 |
|
|
2015
Q1 | $7.27M | Buy |
97,891
+2,890
| +3% | +$215K | 0.02% | 993 |
|
|
2014
Q4 | $5.32M | Buy |
95,001
+9,814
| +12% | +$550K | 0.01% | 1096 |
|
|
2014
Q3 | $3.86M | Buy |
85,187
+2,686
| +3% | +$122K | 0.01% | 1334 |
|
|
2014
Q2 | $3.42M | Buy |
82,501
+8,569
| +12% | +$355K | 0.01% | 1391 |
|
|
2014
Q1 | $5.12M | Buy |
73,932
+2,910
| +4% | +$202K | 0.01% | 1105 |
|
|
2013
Q4 | $4.28M | Buy |
71,022
+9,982
| +16% | +$602K | 0.01% | 1164 |
|
|
2013
Q3 | $3.71M | Buy |
+61,040
| New | +$3.71M | 0.01% | 1229 |
|